Page last updated: 2024-09-03

cimadronate and Benign Neoplasms

cimadronate has been researched along with Benign Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eto, S; Fukumoto, S; Matsumoto, T; Nawata, H; Ogata, E; Onaya, T; Takebe, K	1

Other Studies

1 other study(ies) available for cimadronate and Benign Neoplasms

Article	Year
Treatment of malignancy-associated hypercalcemia with YM175, a new bisphosphonate: elevated threshold for parathyroid hormone secretion in hypercalcemic patients. The Journal of clinical endocrinology and metabolism, 1994, Volume: 79, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Calcium; Diphosphonates; Female; Humans; Hypercalcemia; Male; Middle Aged; Neoplasms; Parathyroid Hormone; Regression Analysis	1994

Article

Year

Treatment of malignancy-associated hypercalcemia with YM175, a new bisphosphonate: elevated threshold for parathyroid hormone secretion in hypercalcemic patients.

The Journal of clinical endocrinology and metabolism, 1994, Volume: 79, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Calcium; Diphosphonates; Female; Humans; Hypercalcemia; Male; Middle Aged; Neoplasms; Parathyroid Hormone; Regression Analysis

1994